Journal Information
Full text access
Does the treatment focused on controlling the activity of the underlying inflammatory disease and reducing the serum level of AA protein improve the prognosis of systemic amyloidosis?
Visits
2983
V. Barrio, F. Ortiz-Herbener
This item has received
Article information